DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth

August F Williams1, David A G Gervasio1, Claire E Turkal1

  • 1Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA, USA.

Nature Cell Biology
|November 17, 2025
PubMed

Insights

Cancer therapies face resistance. Residual cancer cells survive treatment by suppressing immune signals, paradoxically using cell death pathways to regrow, complicating treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Acquired resistance is a major challenge in oncogene-targeted cancer therapies, leading to treatment failure.
  • Tumour evolution and multiple resistance mechanisms complicate therapeutic strategies for resistant cancers.
  • Understanding adaptive processes that initiate resistance is crucial for developing preventative strategies.

Purpose of the Study:

  • To investigate the mechanisms by which residual cancer persister cells survive oncogene-targeted therapy.
  • To elucidate the role of drug stress-induced signaling in persister cell growth arrest and escape.
  • To identify potential targets for preventing acquired drug resistance.

Main Methods:

  • Analysis of residual cancer persister cells surviving oncogene-targeted therapy.
  • Investigating the role of type I interferon signaling in drug stress-induced growth arrest.
  • Utilizing genetic manipulation to assess the function of apoptotic machinery components (caspases, DNA fragmentation factor B, ATF3) in persister cell regrowth.
  • Measuring interferon-stimulated gene (ISG) expression and DNA damage in persister cells.

Main Results:

  • Residual cancer persister cells are growth arrested by drug stress-induced type I interferon signaling.
  • Persister cells suppress interferon-stimulated genes (ISGs) to escape growth arrest by leveraging apoptotic machinery.
  • Sublethal engagement of apoptotic caspases activates DNA fragmentation factor B, leading to DNA damage and ATF3 induction.
  • ATF3 suppresses ISG expression, enabling persister cell regrowth; deficiency in DNA fragmentation factor B or ATF3 prevents regrowth due to high ISG expression.

Conclusions:

  • Sublethal apoptotic stress paradoxically promotes the regrowth of residual cancer cells that survive drug treatment.
  • Targeting the interplay between apoptotic pathways and interferon signaling may offer strategies to overcome acquired resistance.
  • Understanding persister cell adaptive mechanisms is key to developing more effective and durable cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K